Enzyme-free and label-free fluorescence sensor for the detection of liver cancer related short gene

Non-invasive early diagnosis of liver cancer is the most effective way to improve the survival rate. In this paper, we developed a label-free and enzyme-free fluorescent biosensor based on target recycling and Thioflavin T (ThT) induced G-quadruplex formation for MXR7 (liver cancer related short gen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biosensors & bioelectronics 2015-04, Vol.66, p.399-404
Hauptverfasser: Li, Xianghui, Gan, Longjie, Ou, Qishui, Zhang, Xi, Cai, Shuxian, Wu, Dongzhi, Chen, Mei, Xia, Yaokun, Chen, Jinghua, Yang, Bin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Non-invasive early diagnosis of liver cancer is the most effective way to improve the survival rate. In this paper, we developed a label-free and enzyme-free fluorescent biosensor based on target recycling and Thioflavin T (ThT) induced G-quadruplex formation for MXR7 (liver cancer related short gene) detection in human serum. The proposed sensor can detect the target DNA in the concentration range of 0–350fM with the detection limit as low as 10fM. Due to the outstanding structural selectivity of ThT for G-quadruplex, this sensor possesses better discrimination ability and higher sensitivity. Furthermore, this enzyme-free and label-free fluorescence sensor has demonstrated to be capable of detecting target DNA in human serum samples because of its high selectivity and sensitivity. The mechanism employed in this study represents a promising path toward directing liver cancer detection in human serum. In addition, this strategy may be extended to detect other cancer related genes by choosing a rational DNA probe according to different sequences of targets. •A novel, label-free and enzyme-free signal amplification fluorescence sensor was proposed.•It is an attempt to detect liver cancer by related short gene.•This strategy exhibits high sensitivity, good selectivity, and low cost.
ISSN:0956-5663
1873-4235
DOI:10.1016/j.bios.2014.11.049